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Cells would then steer by using local
receptor signals to increase the efficacy
of membrane protrusion and adhesion
on the side where chemoattractant con-
centration is higher.
The combined results from Falke’s
and Cheng’s groups now suggest that
calcium flickers are key components of
both the local steering and the cell polarity
machineries. However, a clear resolution
of which factors act upstream and play
causal roles in creating changes in the
direction of migration, which factors act
downstream to transduce these signals
into mechanical forces, and whether
these activities can be separated at all,
remains to be figured out.
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Within the developing and adult heart, the fibroblast is often dismissed asmerely a structural element, impor-
tant just to mechanical integrity or to scarring when excessive in disease. Ieda et al. in this issue of Develop-
mental Cell now report an essential programof paracrine factor production in cardiac fibroblasts that controls
heart muscle cell growth, driving cycling or enlargement depending on the fibroblasts’ developmental stage.The heart is the earliest organ to form
in the incipient embryo. Its complex
three-dimensional patterning is essential
to survival even in midgestation, and
derangements of cardiac morphogenesis
comprise the commonest birth defects of
the newborn (Olson and Schneider, 2003).
Highly ordered spatial programs of prolif-
erative growth underlie the expansion of
early cardiac progenitor cells, elongation
of the linear heart tube, and thickening of
the ventricular walls to ensure appropriate
mechanical pump function. By contrast,
most growth of the heart after birth occurs
by cell enlargement. Whereas much is
known about developmentally regulated
transitions in cell cycle machinery that
execute this shift from hyperplasia to
hypertrophy as the predominant mode of
organ-level growth, such changes cannotby themselves explain the intricate spatial
patterning of growth that ultimately fash-
ions the working heart.
A number of essential mitogenic path-
ways drive the proliferation of cardiomyo-
cytes or of their predecessors in the
embryo, including neuregulins (Iwamoto
and Mekada, 2006), bone morphogenetic
proteins (Chen et al., 2004), fibroblast
growth factors (Lavine et al., 2005), canon-
ical Wnts (Qyang et al., 2007), Notch
(Grego-Bessa et al., 2007), and platelet-
derived growth factor (Kang et al., 2008).
Local sources of cardiac mitogens are
also known and include specialized
epithelial layers that overlie and underline
ventricular muscle itself—the epicardium
and endocardium, respectively (Lavine
et al., 2005). The instigating logic of the
present study is concern that signalsDevelopmental Cell 16emanating from these two surface layers,
even combined,might be spatially implau-
sible to account for the sustainedprolifera-
tion of the ventricular wall in late gestation,
i.e., that themyocardiumbecomesso thick
the signals could not reach all cells.
This seeming incongruity prompts the
logical hypothesis that other local signals
might also participate in cardiomyocyte
growth control. The present study shows
with admirable conclusiveness that a third
set of paracrine signals exists, produced
by cardiac fibroblasts, which are dispersed
alongside the ventricularmyocytes and are
generated as ventricular wall thickening
ensues (Ieda et al., 2009), a process that
involves ‘‘compaction,’’ assimiliation of
the spongy (‘‘trabecular’’) chamber-facing
myocardium into a consolidated muscular
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PreviewsUsingmultiple criteria to demarcate fibro-
blasts in the embryonic heart, including
expressionof vimentin, Thy-1, andDiscoidin
Domain Receptor 2, Ieda et al. (2009) show
that cardiac fibroblasts develop coincident
with ventricular compaction. They then
prove that embryonic cardiac fibroblasts
promote cardiomyocyte proliferation by
coculturing the fibroblasts with genetically-
tagged cardiac muscle cells from Nkx2.5-
YFP mice (created by crossing a ventricular
enhancer-Cre line with a Cre-activated
EYFP reporter line), which express the fluo-
rescent protein exclusively within the
ventricular myocyte lineage.
Expression profiling identified several
growth factors that are enriched in embry-
onic heart fibroblasts and may contribute
to the fibroblasts’ effect on cardiomyocytes.
One of these factors, heparin-binding
epidermal growth factor (HB-EGF), was
then shown to induceproliferation in embry-
onic cardiomyocyte. In contrast, coculture
with adult cardiac fibroblasts induced
more hypertrophy but less proliferation,
consistent with the postnatal shift in mode
of growth; indeed, a known hypertrophy-
inducing factor, IL-6, was upregulated in
the fibroblasts from adult hearts.
Mechanistically, themitogenicactivityof
HB-EGF depended on embryonic fibro-
blasts’ production of two components of
the extracellular matrix—collagen and
fibronectin—and was augmented in
culture by coating disheswith eithermatrix
protein. The proliferative effect also was
contingent on embryonic cardiomyocytes’
receptors for collagen and fibronectin,
being blocked by an interfering antibody
against integrin b1, enhanced by forced
expression of the integrin, and inhibited
by a dominant-interfering mutation. Strik-
ingly, cardiomyocyte-specific deletion of
integrin b1 caused perinatal lethality, with
ventricular hypoplasia discernible by
E14–15 and marked defects ultimately in
compact layer growth.
Thus, Ieda et al. (2009) define an intercel-
lular circuit that couples fibroblasts to cardi-
omyocytes and coordinates secreted
signals for cardiac organogenesis. These
findings reinforce a body of pioneering
work on HB-EGF and its importance to the
heart. HB-EGF directly binds and activates
both the EGF receptor (EGFR) and its rela-
tive ErbB4 and, indirectly, activates ErbB2
and ErbB3 via receptor heterodimerization.
Notwithstanding the known significance162 Developmental Cell 16, February 17, 200of the EGF relative neuregulin in cardiac
morphogenesis, deleting just HB-EGF
prevents normal phosphorylation of ErbB2
and ErbB4 in embryonic hearts (Iwamoto
and Mekada, 2006); deletion of either
receptor suffices for a hypocellular ven-
tricular wall and defective trabeculation.
Cardiac development also requires the
appropriate processing of HB-EGF, re-
leasing soluble ligand through shedding of
the ectodomain: HB-EGF is produced as
a membrane-anchored protein (proHB-
EGF) that can signal to neighboring cells as
a juxtacrine factor but can also be cleaved
by ADAM family disintegrin-metalloprotei-
nases. The phenotype of HB-EGF null
mice is recapitulatedbymiceexpressingun-
cleavable pro-HB-EGF and, among the
ADAM family proteins, TACE/ADAM17 is
most essential for the developing heart
(Iwamoto and Mekada, 2006).
Although HB-EGF was known to be crit-
ical for cardiac organogenesis, determining
itsdirect impactoncardiacmyocytegrowth
has, until now, been complicated by
abnormal heart valve formation in knock-
outs of the pathway and obscured by
indirect consequences of defective valve
function,namely, adaptiveandmaladaptive
changes in ventricular structure in response
to the abnormal workload on the heart. The
present study elucidates mechanisms
underlining the direct effects of HB-EGF
on ventricular muscle growth, suggesting
that embryonic cardiac fibroblasts’ secre-
tion of HB-EGF and specific enabling
proteins of the extracellular matrix creates
a microenvironment that permits b1-integ-
rin-mediated proliferation to transpire.
Cells’ binding toECMvia integrins regulates
proliferation in at least two ways—via non-
receptor protein kinases (focal adhesion
kinase, integrin-linked kinase) and via
receptor tyrosine kinases including ErbB2
(Guo et al., 2006). Much interesting work
lies ahead to clarifywhichmediators enable
b1-integrin to underpin the effect of HB-
EGF on heart growth. Although the present
study emphasizes the critical early role of
HB-EGF as a fibroblast-derived mitogen
for myocardium, HB-EGF holds functional
importance in pathological hypertrophy as
well, since shedding of HB-EGF by
ADAM12 allows biomechanical and phar-
macological signals like excessive work-
load and G protein-coupled receptors to
trigger myocyte enlargement in various
cardiac disorders (Asakura et al., 2002).9 ª2009 Elsevier Inc.In summary, Ieda et al. (2009) identify an
unexpected role for cardiac fibroblasts
during both embryonic development and
postnatal life, creating a time-specific
microenvironment that drives cardiomyo-
cyte growth in both its proliferative and
hypertrophic forms. These results suggest
that the interstitiumisnotameresupportive
structure but rather an instructive secretory
compartment that informs cardiac organo-
genesisand later responses toheart stress.
Manyquestions remain.What regulates the
regulators? (For the moment, the develop-
mental control of growth factor production
in cardiac fibroblasts is unexplained.) Do
myocyte-derived signals affect fibroblast
function? What heterogeneities of ‘‘fibro-
blasts’’ exist? Might fibroblasts also
execute chamber-specific programs?
Although the current study concerns fibro-
blasts’ communication with cardiomyo-
cytes themselves, does HB-EGF play
a role with cardiac-resident progenitors?
Does dysregulation of this novel pathway
occur in disease? Might the pathway be
fruitfully exploited toward the enticing
translational goal of enhancing regenera-
tive growth?
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